• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲基化的DNA和MeCP2招募组蛋白去乙酰化酶以抑制转录。

Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.

作者信息

Jones P L, Veenstra G J, Wade P A, Vermaak D, Kass S U, Landsberger N, Strouboulis J, Wolffe A P

机构信息

Laboratory of Molecular Embryology, National Institute of Child Health and Human Development, National Institute of Health, Bethesda, Maryland 20892-5431, USA.

出版信息

Nat Genet. 1998 Jun;19(2):187-91. doi: 10.1038/561.

DOI:10.1038/561
PMID:9620779
Abstract

CpG methylation in vertebrates correlates with alterations in chromatin structure and gene silencing. Differences in DNA-methylation status are associated with imprinting phenomena and carcinogenesis. In Xenopus laevis oocytes, DNA methylation dominantly silences transcription through the assembly of a repressive nucleosomal array. Methylated DNA assembled into chromatin binds the transcriptional repressor MeCP2 which cofractionates with Sin3 and histone deacetylase. Silencing conferred by MeCP2 and methylated DNA can be relieved by inhibition of histone deacetylase, facilitating the remodelling of chromatin and transcriptional activation. These results establish a direct causal relationship between DNA methylation-dependent transcriptional silencing and the modification of chromatin.

摘要

脊椎动物中的CpG甲基化与染色质结构改变和基因沉默相关。DNA甲基化状态的差异与印记现象和致癌作用有关。在非洲爪蟾卵母细胞中,DNA甲基化主要通过组装抑制性核小体阵列使转录沉默。组装到染色质中的甲基化DNA结合转录抑制因子MeCP2,MeCP2与Sin3和组蛋白去乙酰化酶共分离。抑制组蛋白去乙酰化酶可解除MeCP2和甲基化DNA介导的沉默,促进染色质重塑和转录激活。这些结果确立了DNA甲基化依赖性转录沉默与染色质修饰之间的直接因果关系。

相似文献

1
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.甲基化的DNA和MeCP2招募组蛋白去乙酰化酶以抑制转录。
Nat Genet. 1998 Jun;19(2):187-91. doi: 10.1038/561.
2
Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation.激活时甲基化的人类多药耐药基因(MDR1)上甲基-CpG结合蛋白2和组蛋白去乙酰化酶1的快速释放
Mol Cell Biol. 2002 Mar;22(6):1844-57. doi: 10.1128/MCB.22.6.1844-1857.2002.
3
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.甲基化CpG结合蛋白MeCP2介导的转录抑制作用涉及一种组蛋白去乙酰化酶复合物。
Nature. 1998 May 28;393(6683):386-9. doi: 10.1038/30764.
4
Purification of the MeCP2/histone deacetylase complex from Xenopus laevis.从非洲爪蟾中纯化MeCP2/组蛋白脱乙酰酶复合物。
Methods Mol Biol. 2001;181:297-307. doi: 10.1385/1-59259-211-2:297.
5
The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation.甲基化CpG结合蛋白MeCP2将DNA甲基化与组蛋白甲基化联系起来。
J Biol Chem. 2003 Feb 7;278(6):4035-40. doi: 10.1074/jbc.M210256200. Epub 2002 Nov 9.
6
Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation.甲基化介导的前病毒沉默与MeCP2募集及局部组蛋白H3去乙酰化有关。
Mol Cell Biol. 2001 Dec;21(23):7913-22. doi: 10.1128/MCB.21.23.7913-7922.2001.
7
Co-repressor complexes and remodelling chromatin for repression.共抑制复合物与染色质重塑以实现基因抑制。
Biochem Soc Trans. 2000;28(4):379-86.
8
Epigenetic regulation of metallothionein-i gene expression: differential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins.金属硫蛋白 - I 基因表达的表观遗传调控:DNA 甲基转移酶和甲基 CpG 结合蛋白对甲基化和未甲基化启动子的差异调控。
J Cell Biochem. 2006 Apr 15;97(6):1300-16. doi: 10.1002/jcb.20738.
9
Active repression of methylated genes by the chromosomal protein MBD1.染色体蛋白MBD1对甲基化基因的主动抑制。
Mol Cell Biol. 2000 Feb;20(4):1394-406. doi: 10.1128/MCB.20.4.1394-1406.2000.
10
Histone deacetylase directs the dominant silencing of transcription in chromatin: association with MeCP2 and the Mi-2 chromodomain SWI/SNF ATPase.组蛋白去乙酰化酶指导染色质中转录的主要沉默:与MeCP2及Mi-2染色质结构域SWI/SNF ATP酶的关联。
Cold Spring Harb Symp Quant Biol. 1998;63:435-45. doi: 10.1101/sqb.1998.63.435.

引用本文的文献

1
All-in-one vectors for epigenetic CRISPR inhibition of in facioscapulohumeral muscular dystrophy.用于面肩肱型肌营养不良症表观遗传CRISPR抑制的一体化载体
Mol Ther Methods Clin Dev. 2025 Aug 7;33(3):101546. doi: 10.1016/j.omtm.2025.101546. eCollection 2025 Sep 11.
2
Exploring the uncharted role of cell senescence in rare diseases.探索细胞衰老在罕见病中未知的作用。
Orphanet J Rare Dis. 2025 Sep 1;20(1):465. doi: 10.1186/s13023-025-03778-1.
3
Epigenetic Modifications in Osteosarcoma: Mechanisms and Therapeutic Strategies.
骨肉瘤中的表观遗传修饰:机制与治疗策略
Life (Basel). 2025 Jul 28;15(8):1202. doi: 10.3390/life15081202.
4
A subset of Polycomb-targeted transcription factor genes become hypermethylated yet upregulated in colorectal cancer.在结直肠癌中,一部分受多梳蛋白靶向的转录因子基因发生高甲基化但表达上调。
Comput Struct Biotechnol J. 2025 Aug 5;27:3556-3564. doi: 10.1016/j.csbj.2025.07.057. eCollection 2025.
5
TET1 functions as a tumor suppressor in lung adenocarcinoma through epigenetic remodeling and immune modulation.TET1通过表观遗传重塑和免疫调节在肺腺癌中发挥肿瘤抑制作用。
Epigenetics Chromatin. 2025 Aug 11;18(1):53. doi: 10.1186/s13072-025-00617-2.
6
Revealing function-altering MECP2 mutations in individuals with autism spectrum disorder using yeast and Drosophila.利用酵母和果蝇揭示自闭症谱系障碍个体中改变功能的MECP2突变
Genetics. 2025 Sep 3;231(1). doi: 10.1093/genetics/iyaf121.
7
Epigenetic Regulation and Therapeutic Targeting of Alternative Splicing Dysregulation in Cancer.癌症中可变剪接失调的表观遗传调控与治疗靶点
Pharmaceuticals (Basel). 2025 May 12;18(5):713. doi: 10.3390/ph18050713.
8
Transcription factors that define the epigenome structures and transcriptomes in microglia.定义小胶质细胞表观基因组结构和转录组的转录因子。
Exp Hematol. 2025 May 25;149:104814. doi: 10.1016/j.exphem.2025.104814.
9
Exploring the complexity of MECP2 function in Rett syndrome.探索雷特综合征中MECP2功能的复杂性。
Nat Rev Neurosci. 2025 May 13. doi: 10.1038/s41583-025-00926-1.
10
Epigenome editing-mediated restoration of expression by demethylation of CpG island shore in porcine fibroblasts.通过猪成纤维细胞中CpG岛岸去甲基化实现的表观基因组编辑介导的表达恢复。
Biochem Biophys Rep. 2025 Mar 11;42:101973. doi: 10.1016/j.bbrep.2025.101973. eCollection 2025 Jun.